Predictive genetic testing is used to detect genetic diseases such as Huntington’s diseases, cancer, and neuro-degenerative diseases. Predictive genetic testing identifies specific gene alteration, DNA analysis and genetic material. A growing number of tests to help treat and manage individual health conditions is anticipated to drive the market for predictive genetic testing over the study period.
Autoimmune disease is a chronic health condition caused when the immune system starts attacking its own body’s cells. The Centers for Disease Prevention and Control reports around 22.7% or 54.4 million adults in America had doctor-diagnosed arthritis as per the National Health Interview Survey 2013-2015, with a higher prevalence in women (23.5%) than in men (18.1%).
Bronchitis is one of the most common respiratory diseases observed in developed as well as developing countries. Chronic bronchitis is life-threatening most of the times and the Centers for Disease Control and Prevention recorded that 8.6 million people were diagnosed with chronic bronchitis in year 2016 in the U.S with 0.2% of mortality.
The global osteoporosis market is currently eyeing a staggering $14,300 million valuation during the forecast period (2013-2022), claims Market Research Future (MRFR) in a detailed study. Booming urbanization and technological advancements may have a lot to do with the progressing world, but they have some adverse effects too.
Growing use of enzymes in the treatment of chronic diseases, increasing demand for active therapeutics and rising incidences of digestive enzyme disorders are some of the key factors driving the growth of the specialty enzymes market in pharmaceuticals, biotechnological science and diagnostics.